IMMUNOGLOBULIN G2, ANTI-(HUMAN NERVE GROWTH FACTOR) (HUMAN MONOCLONAL 4D4 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 4D4 LIGHT CHAIN, DIMER
Pain, Radiating
Janssen Research & Development, LLCmonoclonal_antibodyPhase 2Dormant
C
35/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 20/ 100
- Competitive Position
- 95/ 100
Competitive context
8 Active assets in the Pain, Radiating cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Triamcinalone University of Miami | Phase 4 | BBB |
LIDOCAINE Sheba Medical Center | Phase 4 | BBB |
sp-102 Semnur Pharmaceuticals, Inc. | Phase 3 | BB |
DEXAMETHASONE Semnur Pharmaceuticals, Inc. | Phase 4 | BB |
Celestone Sheba Medical Center | Phase 4 | BB |
View all 37 →
Same molecule, other indications
IMMUNOGLOBULIN G2, ANTI-(HUMAN NERVE GROWTH FACTOR) (HUMAN MONOCLONAL 4D4 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 4D4 LIGHT CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →